Corbus Pharmaceuticals Holdings, Inc. Operating Lease Liability
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Operating Lease Liability of $4.26 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $4.26M.
- 2026-03-31: Operating Lease, Liability $1.21M.
- 2025-12-31: Operating Lease, Liability $1.63M.
- 2025-09-30: Operating Lease, Liability $2.05M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $4.26M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.63M 10-K · filed 2026-03-09 |
| 2025-09-30 | $2.05M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.46M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.85M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $3.24M 10-K · filed 2025-03-11 |
| 2024-09-30 | $3.61M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.98M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $4.33M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.68M 10-K · filed 2024-03-12 |
| 2023-09-30 | $5.01M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.33M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.65M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.96M 10-K · filed 2023-03-07 |
| 2022-09-30 | $6.25M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.54M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.82M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.09M 10-K · filed 2022-03-08 |
| 2021-09-30 | $7.35M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $7.61M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.86M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.10M 10-K · filed 2021-03-15 |
| 2020-09-30 | $8.33M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.48M 10-Q/A · filed 2020-08-31 |
| 2020-03-31 | $8.60M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.69M 10-K · filed 2020-03-16 |
| 2019-09-30 | $8.33M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.62M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.32M 10-Q · filed 2019-05-09 |
| 2019-01-02 | $3.80M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |